Author + information
- Received March 27, 1992
- Revision received November 4, 1992
- Accepted January 7, 1993
- Published online July 1, 1993.
- Robert L. Incorvati, DO, FACC,
- Stuart G. Tauberg, MD,
- Michael J. Pecora, MD, FACC,
- Robin S. Macherey, RN,
- Sinda B. Dianzumba, MD and
- Bryan C. Donohue, MD, FACC∗
- ↵∗Address for correspondence: Bryan C. Donohue, MD, Allegheny General Hospital, Cardiac Catheterization Laboratory, 320 East North Avenue, Pittsburgh, Pennsylvania 15212.
- Mitchell W. Krucoff, MD, FACC∗
Objectives. This study was designed to determine the efficacy of synchronized coronary sinus retroperfusion of arterial blood in reducing myocardial ischemia associated with the performance of high risk coronary angioplasty.
Background. Previous animal and clinical work has demonstrated the efficacy of this technique in supporting ischemic myocardium.
Methods. Twenty-one patients were randomized to alternately receive coronary sinus retroperfusion support during either the second or the third coronary angioplasty balloon inflation, after an initial unsupported brief control inflation. Myocardial ischemia was assessed by the extent of echocardiographic left ventricular wall motion abnormality, quantified ST segment deviation and hemodynamic and anginal variables during balloon inflations performed with and without coronary sinus retroperfusion support. Regional wall motion score was defined as hyperkinesia (−1), normokinesia (0), hypokinesia (+1), akinesia (+2) and dyskinesia (+3).
Results. A reduction in the echocardiographic left anterior descending regional wall motion score in retroperfusion-supported (1.7 ± 2.1) versus unsupported (2.7 ± 1.6) inflations (p < 0.05) was noted. Twelve-lead electrocardiographic monitoring revealed no additional ST segment deviation during supported (173 ± 95 s) compared with unsupported (129 ± 87 s) angioplasty inflations despite a significantly longer duration of supported inflations (p < 0.004). Mean and peak systolic coronary sinus pressures differed during supported inflations (21 ± 6 and 44 ± 13 mm Hg) versus unsupported inflations (10 ± 4 and 16 ± 5 mm Hg) (p < 0.001). There was no difference in hemodynamic or anginal variables.
Conclusions. A reduction in ischemia as defined by wall motion abnormality during retroperfusion-supported compared with unsupported angioplasty balloon inflations was documented. No additional ST segment deviation occurred during retroperfusion-supported compared with unsupported balloon inflations despite a significantly longer duration of supported inflations. No difference in hemodynamic or anginal variables was noted.
☆ This study was supported by a grant from Retroperfusion Systems Inc., San Clemente, California.
- Received March 27, 1992.
- Revision received November 4, 1992.
- Accepted January 7, 1993.